Clinical Trials Browser

Phase 2 × NETWORK × peginterferon alfa-2b × Clear all

NCT00049530 2023-06-29

PEG-Interferon Alfa-2b in Treating Patients With Stage IV Melanoma

Phase 2 Completed

32 enrolled 8 charts

Melanoma

NCT00467077 2017-03-17

Gefitinib and PEG-Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer

Phase 2 Terminated

21 enrolled 8 charts

Carcinoma, Renal Cell, Kidney Neoplasms